VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...
Variational AI Inc., a Vancouver startup that uses generative artificial intelligence to discover therapeutic drugs, has signed a two-year development deal with Merck & Co. Inc. MRK-N that could be ...
New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies Variational AI, the company behind Enki, an advanced foundation model for small molecule drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback